Carl Zeiss Meditec shows solid recovery signs, especially in China/US, with strong growth in equipment and consumables. Read ...
Carl Zeiss Meditec reported a fall in net profit ... as it warned of a continuing challenging macroeconomic environment. The German medical technology company reported Wednesday net income of ...
Hosted on MSN1mon
Carl Zeiss Meditec stock falls on Q1 resultsInvesting.com -- Shares of Carl Zeiss Meditec AG (ETR ... to invest in equipment amid expectations of stimulus packages for medical equipment. Additionally, price declines in intraocular lenses ...
Hosted on MSN1mon
Goldman Sachs lifts Carl Zeiss Meditec stock to NeutralO n Wednesday, Goldman Sachs analyst Richard Felton upgraded Carl Zeiss Meditec AG (AFX:GR) (OTC: CZMWY), a medical technology company with a $5.2 billion market cap, from Sell to Neutral and ...
J.P. Morgan analyst David Adlington maintained a Sell rating on Carl Zeiss Meditec (0DHC – Research Report) today. The company’s shares closed ...
Here is another substantial technology contribution from Carl Zeiss to the battle against infectious diseases: Primo Star iLED, the new tuberculosis test microscope. Primo Star iLED is the ...
ZEISS Xradia 810 Ultra Nanoscale X-Ray Imaging from Carl Zeiss High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links ...
(Il Sole 24 Ore Radiocor) - Milano, 11 mar - Carl Zeiss Meditec shares were sharply higher in Frankfurt trade after Goldman Sachs raised its recommendation on the German medical technology group ...
Carl Zeiss Meditec AG ( ETR:AFX ) shareholders should be happy to see the share price up 21% in the last month. But... ZEISS Medical Technology announced today that the MEL® 90 received approval from ...
J.P. Morgan analyst Anchal Verma maintained a Sell rating on Carl Zeiss Meditec (0DHC – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results